PDF《www.nature.com/npjschz》

Self. Janssen, Honoraria for a presentation;

Self. Part 4: Fondo de Investigación Sanitaria, Instituto de Investigación Carlos III, Health Ministry, Spain, Grant PI11/1340;

Inmaculada Baeza, Olga Puig, Montserrat Dolz. Fundación AliciaKoplowitz, Grant in 2013;

Inmaculada Baeza, Elena de la Serna. Baudin, Grégoire: Part 2: Assistance Publique H?pitaux de Paris, Income;

Self. Part 4: Fondation FondaMental, FondaMental Advanced Centre of Experise (FACE) Grant received;

Self. Part 5: Assistance Publique H?pitaux de Paris, Main employer;

Self. Ben-Zeev, Dror: Part 1: Pear Therapeutics, Consulting/ licensing intervention content;

Self. Part 2: Pear Therapeutics, Consulting/ licensing intervention content;

Self. Part 3: Pear Therapeutics, Consulting/ licensing intervention content;

Self. Bernardo Arroyo, Miguel: Part 4: ABBiotics, consultant, grant research;

Miguel Bernardo. Adamed, grant research, advisory board;

Miguel Bernardo. Boehringer, consultant;

Miguel Bernardo. Eli Lilly, grant research;

Miguel Bernardo. Ferrer, consultant, grant research, advisory board;

Miguel Bernardo. Forum Pharma- ceuticals, grant research, advisory board;

Miguel Bernardo. Janssen-Cilag, consultant, advisory board;

Miguel Bernardo. Lundbeck, consultant, grant research, advisory board;

Miguel Bernardo. Otsuka, consultant, grant research, advisory board;

Miguel Bernardo. P?zer, consultant, advisory board;

Miguel Bernardo. Bioque, Miquel: Part 1: ADAMED, research support;

Self. JANSSEN, Honararia;

Self. OTSUKA, Honoraria;

Self. LUNDBECK, Honoraria;

Self. FERRER, consultant;

MBi, CGR, MBe. Bodnar, Michael: Part 1: Janssen-Ortho/MITACS, Financial Sup- port;

Self. Part 4: Otsuka/Lundbeck Alliance/CIHR, Operational Grant;

Martin Lepage, Michael Bodnar, Ashok Malla, Ridha Joober. Bogers, Jan: Part 1: Hemocue Sweden, unrestricted grant, without restrictions in permorfance nor publication;

Self. Bowie, Christopher: Part 1: Abbvie, Advisor;

Self. Boehringer- Ingelheim, Advisor;

Self. Lundbeck, Advisor;

Self. Takeda, Advisor;

Self. Otsuka, Advisor;

Presenter. www.nature.com/npjschz All rights reserved 2334-265X/16 ?

2016 Schizophrenia International Research Society/Nature Publishing Group Buchanan, Robert: Part 1: AbbVie, Consultant/Advisory Board;

Self. Amgen, Advisory Board;

Self. Boehringer Ingelheim RCV, Advisory Board;

Self. EnVivo (now Forum), Advisory Board;

Self. P?zer, DSMB;

Self. Takeda, Advisory Board;

Self. Buonaguro, Elisabetta: Part 4: Lundbeck, Unrestricted research funding;

Andrea de Bartolomeis. Astra Zeneca, Unrestricted research funding;

Andrea de Bartolomeis. Janssen-Cilag, Unrest- ricted research funding;

Andrea de Bartolomeis. Part 5: Lundbeck Pharmaceutical Services LLC, Employer;

Anna Eramo. Burdick, Katherine: Part 1: Takeda Lundbeck, Ad Board;

Self. DSP Pharma, Ad Board;

Self. Campbell-Angah, Danielle: Part 1: company 1, consultant;

Self. Part 3: company one, stocks;

self. Caron, Marc: Part 1: Lundbeck, Counsulting;

Self. Omeros, Consulting;

Self. Acadia, Equity;

Self. Part 5: P?zer, Employe/ Equity;

Patricio O'

Donnell. P?zer, Employe;

Steven Gee. Catalan Campos, Rosa: Part 1: Lilly, Paid for talks (honoraria);

Self. Lundbeck, Paid for talks (honoraria);

Self. Part 4: Lilly, Registration and travels to Congresses;

Rosa Catalán. Lundbeck, Registration and travels to Congresses;

Rosa Catalán. Janssen, Registration and travels to Congresses;

Rosa Catalán. Ferrer, Registration and travels to Congresses;